SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--March 16, 2006--Hana Biosciences (AMEX:HBX), a biopharmaceutical company focused on advancing cancer care, reported its results of operations for 2005 and the filing of its annual report on Form 10-K.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--March 16, 2006--Hana Biosciences (AMEX:HBX), a biopharmaceutical company focused on advancing cancer care, reported its results of operations for 2005 and the filing of its annual report on Form 10-K.
